Improvement of pharmaceutical potential of all-trans retinoic acid with hydroxypropyl-β-cyclodextrin

被引：2

作者：

Takahashi, Keiko ^{[1
]}

Morimoto, Sayo ^{[1
]}

Nakamura, Hiroto ^{[1
]}

Narusawa, Toshiaki ^{[1
]}

Seki, Taizo ^{[2
,4
]}

Ooe, Masahiko ^{[3
,4
]}

Aoi, Keigo ^{[2
]}

Takada, Akiyoshi ^{[3
]}

机构：

[1] Tokyo Polytech Univ, Ctr Nanosci & Technol, Fac Engn, Dept Life Sci & Sustainable Chem, Atsugi Kanagawa 2430297, Japan

[2] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan

[3] Osaka Univ, Grad Sch Med, Dept Cosmet Med, Suita, Osaka 5650871, Japan

[4] Tokiwa Pharmaceut Co Ltd, Dev Lab, Chuou Ku, Kobe Hyougo 6508521, Japan

来源：

JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY | 2011年 / 70卷 / 3-4期

关键词：

Tretinoin; Hydroxypropyl-beta-cyclodextrin; Skin rejuvenation therapy; Inhibition of side effects; NMR; TOPICAL TRETINOIN; NMR-SPECTROSCOPY; INCLUSION; EFFICACY; COMPLEX;

D O I：

10.1007/s10847-010-9857-6

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) includes all-trans retinoic acid (RA), covering the double-bond area of RA with substituted hydroxypropyl groups on CyD ring, as proved by the nuclear Overhauser effect (NOE) between methylene protons on the hydroxypropyl groups and the proton on RA. The formation of an inclusion complex results in hydrophilicity and stability. The effect of RA/HP-beta-CyD and that of RA without HP-beta-CyD on wrinkle scores and skin elasticity during skin treatment were identical, and the cutaneous stimulus was reduced comparing with RA. The results indicated that the RA/HP-beta-CyD complex should help to realize new approaches in skin rejuvenation therapy.

引用

页码：389 / 396

页数：8

共 50 条

[1] Improvement of pharmaceutical potential of all-trans retinoic acid with hydroxypropyl-β-cyclodextrin
Keiko Takahashi
Sayo Morimoto
Hiroto Nakamura
Toshiaki Narusawa
Taizo Seki
Masahiko Ooe
Keigo Aoi
Akiyoshi Takada
[J]. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2011, 70 : 389 - 396
[2] ENZYMATIC OXIDATION OF ALL-TRANS RETINAL TO ALL-TRANS RETINOIC ACID
BHAT, PV
POISSANT, L
LACROIX, A
[J]. FEDERATION PROCEEDINGS, 1987, 46 (04) : 1187 - 1187
[3] The adjuvant potential of All-trans Retinoic Acid (ATRA) in humans
Mwanza, M.
Chomba, M.
Besa, E.
Chama, M.
Fungika, E.
Kelly, P.
[J]. IMMUNOLOGY, 2013, 140 : 177 - 177
[4] Potential Therapeutic Effect of All-Trans Retinoic Acid on Atherosclerosis
Deng, Qile
Chen, Jixiang
[J]. BIOMOLECULES, 2022, 12 (07)
[5] Vasculitis and all-trans retinoic acid
Fregoni, V
Pastorini, A
Camerone, G
[J]. HAEMATOLOGICA, 1996, 81 (05) : 485 - 486
[6] All-trans retinoic acid induction of sulfotransferases
Maiti, S
Chen, XR
Chen, GP
[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (01) : 44 - 53
[7] HYPERCALCEMIA DUE TO ALL-TRANS RETINOIC ACID
AKIYAMA, H
NAKAMURA, N
NAGASAKA, S
SAKAMAKI, H
ONOZAWA, Y
[J]. LANCET, 1992, 339 (8788): : 308 - 309
[8] ALL-TRANS RETINOIC ACID IN MYELOGENOUS LEUKEMIA
GALLAGHER, RE
WIERNIK, PH
[J]. LANCET, 1991, 338 (8782-3): : 1603 - 1603
[9] All-trans retinoic acid (ATRA) desensitization
Kearney, DM
Ledford, DK
Lockey, RF
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S230 - S230
[10] Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care
Iland, Harry J.
Wei, Andrew
Seymour, John F.
[J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2014, 27 (01) : 39 - 52

← 1 2 3 4 5 →